nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP3A4—chronic kidney failure	0.628	1	CbGaD
Trametinib—MAP2K2—blood plasma—chronic kidney failure	0.00804	0.108	CbGeAlD
Trametinib—MAP2K1—renal system—chronic kidney failure	0.00428	0.0577	CbGeAlD
Trametinib—MAP2K1—cardiovascular system—chronic kidney failure	0.00423	0.057	CbGeAlD
Trametinib—MAP2K1—kidney—chronic kidney failure	0.00414	0.0558	CbGeAlD
Trametinib—MAP2K1—gonad—chronic kidney failure	0.00384	0.0517	CbGeAlD
Trametinib—MAP2K2—renal system—chronic kidney failure	0.00377	0.0508	CbGeAlD
Trametinib—MAP2K2—cardiovascular system—chronic kidney failure	0.00372	0.0502	CbGeAlD
Trametinib—MAP2K2—urethra—chronic kidney failure	0.0037	0.0499	CbGeAlD
Trametinib—MAP2K2—kidney—chronic kidney failure	0.00364	0.0491	CbGeAlD
Trametinib—CYP3A4—urine—chronic kidney failure	0.00361	0.0487	CbGeAlD
Trametinib—MAP2K2—cortex of kidney—chronic kidney failure	0.00355	0.0478	CbGeAlD
Trametinib—MAP2K1—digestive system—chronic kidney failure	0.00351	0.0473	CbGeAlD
Trametinib—MAP2K2—gonad—chronic kidney failure	0.00338	0.0455	CbGeAlD
Trametinib—MAP2K1—blood—chronic kidney failure	0.00335	0.0451	CbGeAlD
Trametinib—MAP2K2—digestive system—chronic kidney failure	0.00309	0.0417	CbGeAlD
Trametinib—MAP2K2—blood—chronic kidney failure	0.00295	0.0397	CbGeAlD
Trametinib—CYP2C8—blood plasma—chronic kidney failure	0.00278	0.0375	CbGeAlD
Trametinib—CYP3A4—blood plasma—chronic kidney failure	0.00189	0.0254	CbGeAlD
Trametinib—CYP2C8—renal system—chronic kidney failure	0.00131	0.0176	CbGeAlD
Trametinib—CYP2C8—kidney—chronic kidney failure	0.00126	0.017	CbGeAlD
Trametinib—CYP2C8—blood—chronic kidney failure	0.00102	0.0137	CbGeAlD
Trametinib—CYP3A4—renal system—chronic kidney failure	0.000884	0.0119	CbGeAlD
Trametinib—CYP3A4—kidney—chronic kidney failure	0.000855	0.0115	CbGeAlD
Trametinib—CYP3A4—digestive system—chronic kidney failure	0.000725	0.00977	CbGeAlD
Trametinib—CYP3A4—blood—chronic kidney failure	0.000691	0.00931	CbGeAlD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—IL6—chronic kidney failure	5.33e-05	0.000179	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PTH—chronic kidney failure	5.3e-05	0.000178	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS1—chronic kidney failure	5.26e-05	0.000176	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FASN—chronic kidney failure	5.26e-05	0.000176	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	5.22e-05	0.000175	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IRS1—chronic kidney failure	5.22e-05	0.000175	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LRP2—chronic kidney failure	5.2e-05	0.000174	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CYBB—chronic kidney failure	5.17e-05	0.000173	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AVP—chronic kidney failure	5.16e-05	0.000173	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	5.15e-05	0.000173	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—KRAS—chronic kidney failure	5.12e-05	0.000172	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD79A—chronic kidney failure	5.08e-05	0.000171	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HBEGF—chronic kidney failure	5.08e-05	0.000171	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	5.08e-05	0.00017	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MLXIPL—chronic kidney failure	5.07e-05	0.00017	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—KRAS—chronic kidney failure	5.03e-05	0.000169	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HBEGF—chronic kidney failure	5.02e-05	0.000168	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—VEGFA—chronic kidney failure	5.01e-05	0.000168	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—RELA—chronic kidney failure	5e-05	0.000168	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—IL6—chronic kidney failure	4.98e-05	0.000167	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	4.97e-05	0.000167	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTH—chronic kidney failure	4.96e-05	0.000166	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS1—chronic kidney failure	4.92e-05	0.000165	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—EDN1—chronic kidney failure	4.91e-05	0.000165	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF23—chronic kidney failure	4.9e-05	0.000164	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCL5—chronic kidney failure	4.87e-05	0.000163	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CYBB—chronic kidney failure	4.84e-05	0.000162	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AVP—chronic kidney failure	4.83e-05	0.000162	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	4.81e-05	0.000161	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—CYP1A1—chronic kidney failure	4.8e-05	0.000161	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—KRAS—chronic kidney failure	4.79e-05	0.000161	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—CYP1A1—chronic kidney failure	4.73e-05	0.000159	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—KRAS—chronic kidney failure	4.71e-05	0.000158	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HBEGF—chronic kidney failure	4.69e-05	0.000157	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—RELA—chronic kidney failure	4.68e-05	0.000157	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC22A2—chronic kidney failure	4.63e-05	0.000155	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NPY—chronic kidney failure	4.61e-05	0.000155	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—EDN1—chronic kidney failure	4.59e-05	0.000154	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF23—chronic kidney failure	4.58e-05	0.000154	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—KRAS—chronic kidney failure	4.56e-05	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCL5—chronic kidney failure	4.55e-05	0.000153	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	4.53e-05	0.000152	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—OXT—chronic kidney failure	4.45e-05	0.000149	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CRH—chronic kidney failure	4.45e-05	0.000149	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—RELA—chronic kidney failure	4.41e-05	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCR5—chronic kidney failure	4.39e-05	0.000147	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NPY—chronic kidney failure	4.31e-05	0.000145	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCG1—chronic kidney failure	4.31e-05	0.000145	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—KRAS—chronic kidney failure	4.26e-05	0.000143	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NCF1—chronic kidney failure	4.26e-05	0.000143	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIP5K1B—chronic kidney failure	4.22e-05	0.000141	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—NFKB1—chronic kidney failure	4.21e-05	0.000141	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NPS—chronic kidney failure	4.21e-05	0.000141	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL6—chronic kidney failure	4.17e-05	0.00014	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CRH—chronic kidney failure	4.16e-05	0.000139	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—OXT—chronic kidney failure	4.16e-05	0.000139	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DRD1—chronic kidney failure	4.13e-05	0.000139	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ARG2—chronic kidney failure	4.13e-05	0.000139	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—RELA—chronic kidney failure	4.13e-05	0.000138	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCR5—chronic kidney failure	4.1e-05	0.000138	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—IL6—chronic kidney failure	4.1e-05	0.000137	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LCAT—chronic kidney failure	4.05e-05	0.000136	CbGpPWpGaD
Trametinib—MAP2K2—Disease—LPL—chronic kidney failure	4.02e-05	0.000135	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CYBA—chronic kidney failure	4e-05	0.000134	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NCF1—chronic kidney failure	3.98e-05	0.000134	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—NFKB1—chronic kidney failure	3.94e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NPS—chronic kidney failure	3.94e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL6—chronic kidney failure	3.9e-05	0.000131	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DRD1—chronic kidney failure	3.87e-05	0.00013	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—IL6—chronic kidney failure	3.83e-05	0.000129	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—VEGFA—chronic kidney failure	3.82e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—F2—chronic kidney failure	3.76e-05	0.000126	CbGpPWpGaD
Trametinib—MAP2K1—Disease—LPL—chronic kidney failure	3.76e-05	0.000126	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CYBA—chronic kidney failure	3.74e-05	0.000126	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CRP—chronic kidney failure	3.72e-05	0.000125	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—NFKB1—chronic kidney failure	3.72e-05	0.000125	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—DDC—chronic kidney failure	3.72e-05	0.000125	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—IL6—chronic kidney failure	3.71e-05	0.000124	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CCR5—chronic kidney failure	3.7e-05	0.000124	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MTHFR—chronic kidney failure	3.62e-05	0.000121	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2B6—chronic kidney failure	3.61e-05	0.000121	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PRKAG2—chronic kidney failure	3.61e-05	0.000121	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PRKD1—chronic kidney failure	3.61e-05	0.000121	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—VEGFA—chronic kidney failure	3.58e-05	0.00012	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—POMC—chronic kidney failure	3.58e-05	0.00012	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	3.55e-05	0.000119	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—F2—chronic kidney failure	3.52e-05	0.000118	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HBEGF—chronic kidney failure	3.51e-05	0.000118	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TGFB1—chronic kidney failure	3.51e-05	0.000118	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CRP—chronic kidney failure	3.48e-05	0.000117	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—NFKB1—chronic kidney failure	3.48e-05	0.000117	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—IL6—chronic kidney failure	3.47e-05	0.000116	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CCR5—chronic kidney failure	3.46e-05	0.000116	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	3.43e-05	0.000115	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—POMC—chronic kidney failure	3.43e-05	0.000115	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ICAM1—chronic kidney failure	3.42e-05	0.000115	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MTHFR—chronic kidney failure	3.38e-05	0.000113	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SREBF2—chronic kidney failure	3.38e-05	0.000113	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—FABP1—chronic kidney failure	3.37e-05	0.000113	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCL2—chronic kidney failure	3.35e-05	0.000112	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HBEGF—chronic kidney failure	3.29e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TGFB1—chronic kidney failure	3.28e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—chronic kidney failure	3.28e-05	0.00011	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCC3—chronic kidney failure	3.27e-05	0.00011	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GCKR—chronic kidney failure	3.27e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IRS1—chronic kidney failure	3.25e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—KRAS—chronic kidney failure	3.25e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—POMC—chronic kidney failure	3.21e-05	0.000108	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ICAM1—chronic kidney failure	3.2e-05	0.000107	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AGXT—chronic kidney failure	3.2e-05	0.000107	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GATM—chronic kidney failure	3.2e-05	0.000107	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LPIN1—chronic kidney failure	3.2e-05	0.000107	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	3.14e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCL2—chronic kidney failure	3.14e-05	0.000105	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2C18—chronic kidney failure	3.13e-05	0.000105	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LRP2—chronic kidney failure	3.13e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—chronic kidney failure	3.07e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AVP—chronic kidney failure	3.05e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IRS1—chronic kidney failure	3.04e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—KRAS—chronic kidney failure	3.04e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IRS1—chronic kidney failure	3e-05	0.000101	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ACAT1—chronic kidney failure	2.93e-05	9.81e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EDN1—chronic kidney failure	2.9e-05	9.72e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL5—chronic kidney failure	2.88e-05	9.64e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—KRAS—chronic kidney failure	2.87e-05	9.63e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AVP—chronic kidney failure	2.85e-05	9.56e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LPL—chronic kidney failure	2.81e-05	9.43e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IRS1—chronic kidney failure	2.81e-05	9.42e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	2.72e-05	9.12e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EDN1—chronic kidney failure	2.71e-05	9.09e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL5—chronic kidney failure	2.69e-05	9.02e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—KRAS—chronic kidney failure	2.69e-05	9.01e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NGF—chronic kidney failure	2.66e-05	8.93e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CPT1A—chronic kidney failure	2.66e-05	8.93e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—chronic kidney failure	2.65e-05	8.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SERPINE1—chronic kidney failure	2.64e-05	8.86e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LPL—chronic kidney failure	2.63e-05	8.82e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LIPC—chronic kidney failure	2.59e-05	8.7e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2C19—chronic kidney failure	2.59e-05	8.7e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCR5—chronic kidney failure	2.59e-05	8.69e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—RELA—chronic kidney failure	2.57e-05	8.62e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	2.56e-05	8.58e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS3—chronic kidney failure	2.52e-05	8.46e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NGF—chronic kidney failure	2.49e-05	8.36e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	2.49e-05	8.34e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—chronic kidney failure	2.47e-05	8.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SERPINE1—chronic kidney failure	2.47e-05	8.29e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCR5—chronic kidney failure	2.42e-05	8.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—RELA—chronic kidney failure	2.4e-05	8.07e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SCARB1—chronic kidney failure	2.4e-05	8.04e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS1—chronic kidney failure	2.37e-05	7.96e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS3—chronic kidney failure	2.36e-05	7.91e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—chronic kidney failure	2.34e-05	7.83e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	2.33e-05	7.83e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SREBF1—chronic kidney failure	2.33e-05	7.8e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1B—chronic kidney failure	2.32e-05	7.79e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCG1—chronic kidney failure	2.31e-05	7.76e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—chronic kidney failure	2.31e-05	7.73e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMGCR—chronic kidney failure	2.26e-05	7.59e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	2.26e-05	7.59e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—F2—chronic kidney failure	2.22e-05	7.45e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ARG2—chronic kidney failure	2.22e-05	7.44e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—FASN—chronic kidney failure	2.22e-05	7.43e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—chronic kidney failure	2.19e-05	7.33e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LCAT—chronic kidney failure	2.17e-05	7.29e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—chronic kidney failure	2.17e-05	7.29e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—NFKB1—chronic kidney failure	2.17e-05	7.27e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—chronic kidney failure	2.16e-05	7.24e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IRS1—chronic kidney failure	2.1e-05	7.05e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—F2—chronic kidney failure	2.08e-05	6.97e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP3A4—chronic kidney failure	2.05e-05	6.88e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	2.04e-05	6.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—NFKB1—chronic kidney failure	2.03e-05	6.8e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—POMC—chronic kidney failure	2.02e-05	6.79e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCA1—chronic kidney failure	2.02e-05	6.77e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DDC—chronic kidney failure	2e-05	6.7e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL2—chronic kidney failure	1.98e-05	6.64e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IRS1—chronic kidney failure	1.97e-05	6.6e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF1—chronic kidney failure	1.95e-05	6.53e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	1.94e-05	6.5e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PRKD1—chronic kidney failure	1.94e-05	6.5e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	1.94e-05	6.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—POMC—chronic kidney failure	1.89e-05	6.35e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL2—chronic kidney failure	1.85e-05	6.22e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SERPINE1—chronic kidney failure	1.85e-05	6.2e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—KRAS—chronic kidney failure	1.83e-05	6.14e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF1—chronic kidney failure	1.82e-05	6.11e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SREBF2—chronic kidney failure	1.81e-05	6.09e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOS3—chronic kidney failure	1.77e-05	5.92e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCKR—chronic kidney failure	1.75e-05	5.88e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCC3—chronic kidney failure	1.75e-05	5.88e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SERPINE1—chronic kidney failure	1.73e-05	5.8e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPIN1—chronic kidney failure	1.72e-05	5.75e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—KRAS—chronic kidney failure	1.71e-05	5.74e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAT—chronic kidney failure	1.71e-05	5.73e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LRP2—chronic kidney failure	1.68e-05	5.64e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	1.68e-05	5.64e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—KRAS—chronic kidney failure	1.67e-05	5.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFB1—chronic kidney failure	1.67e-05	5.59e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RELA—chronic kidney failure	1.66e-05	5.57e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCB1—chronic kidney failure	1.66e-05	5.57e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOS3—chronic kidney failure	1.65e-05	5.54e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LPL—chronic kidney failure	1.58e-05	5.31e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—KRAS—chronic kidney failure	1.56e-05	5.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFB1—chronic kidney failure	1.56e-05	5.23e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RELA—chronic kidney failure	1.55e-05	5.21e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—KRAS—chronic kidney failure	1.54e-05	5.18e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP1A1—chronic kidney failure	1.53e-05	5.13e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—chronic kidney failure	1.49e-05	4.99e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—KRAS—chronic kidney failure	1.44e-05	4.85e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CPT1A—chronic kidney failure	1.43e-05	4.79e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—chronic kidney failure	1.43e-05	4.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NFKB1—chronic kidney failure	1.4e-05	4.7e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARA—chronic kidney failure	1.4e-05	4.69e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—chronic kidney failure	1.39e-05	4.67e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LIPC—chronic kidney failure	1.39e-05	4.67e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	1.39e-05	4.67e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—chronic kidney failure	1.36e-05	4.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NFKB1—chronic kidney failure	1.31e-05	4.4e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SCARB1—chronic kidney failure	1.29e-05	4.31e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS1—chronic kidney failure	1.27e-05	4.27e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—chronic kidney failure	1.27e-05	4.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VEGFA—chronic kidney failure	1.27e-05	4.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—chronic kidney failure	1.26e-05	4.21e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SREBF1—chronic kidney failure	1.25e-05	4.19e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMGCR—chronic kidney failure	1.21e-05	4.07e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VEGFA—chronic kidney failure	1.19e-05	3.99e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—FASN—chronic kidney failure	1.19e-05	3.99e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—chronic kidney failure	1.18e-05	3.94e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFB1—chronic kidney failure	1.17e-05	3.92e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—POMC—chronic kidney failure	1.14e-05	3.82e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFB1—chronic kidney failure	1.09e-05	3.66e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCA1—chronic kidney failure	1.08e-05	3.63e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—KRAS—chronic kidney failure	1.08e-05	3.63e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALB—chronic kidney failure	1.04e-05	3.49e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—KRAS—chronic kidney failure	1.01e-05	3.39e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NOS3—chronic kidney failure	9.94e-06	3.33e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAT—chronic kidney failure	9.17e-06	3.07e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—chronic kidney failure	9.09e-06	3.05e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCB1—chronic kidney failure	8.92e-06	2.99e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—chronic kidney failure	8.8e-06	2.95e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPL—chronic kidney failure	8.5e-06	2.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—chronic kidney failure	8.23e-06	2.76e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	8.21e-06	2.75e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—chronic kidney failure	7.65e-06	2.57e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARA—chronic kidney failure	7.51e-06	2.52e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—POMC—chronic kidney failure	6.12e-06	2.05e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALB—chronic kidney failure	5.58e-06	1.87e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NOS3—chronic kidney failure	5.34e-06	1.79e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—chronic kidney failure	4.88e-06	1.64e-05	CbGpPWpGaD
